Literature DB >> 20333624

Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus development.

Philipp Enghard1, Jens Y Humrich, Vantrung T Chu, Erwin Grussie, Falk Hiepe, Gerd-Rüdiger Burmester, Andreas Radbruch, Claudia Berek, Gabriela Riemekasten.   

Abstract

B1a B cells have been implicated in the pathogenesis of systemic lupus erythematosus; however, their precise contribution to the disease remains unclear. Here we analysed isotype expression, organ accumulation and autoreactivity of B1a cells in the NZB/W F1 murine model for systemic lupus erythematosus using flow cytometry, ELISPOT and adoptive cell transfer. In the course of lupus, the B1a compartment is expanded and B1a cells class switch to IgG. Class-switched B1a B cells were excluded from the peritoneal cavity but accumulated in the spleen and target organs such as kidneys and thymus. Autoreactive B1a B cells preferentially class switch, which leads to a subsequent loss of autoreactive B1a cells from the peritoneal cavity. We propose a model whereby autoreactive B1a B cells become activated early in the course of lupus and class switch to IgG. These autoreactive B1a B cells accumulate in the spleen and affected organs where they presumably secrete autoantibodies and contribute to the local and systemic pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333624     DOI: 10.1002/eji.200940050

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  24 in total

Review 1.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 2.  Contribution of B-1a cells to systemic lupus erythematosus in the NZM2410 mouse model.

Authors:  Zhiwei Xu; Laurence Morel
Journal:  Ann N Y Acad Sci       Date:  2015-02-26       Impact factor: 5.691

3.  The NZM2410-derived lupus susceptibility locus Sle2c1 increases Th17 polarization and induces nephritis in fas-deficient mice.

Authors:  Zhiwei Xu; Carla M Cuda; Byron P Croker; Laurence Morel
Journal:  Arthritis Rheum       Date:  2011-03

4.  Concordance of increased B1 cell subset and lupus phenotypes in mice and humans is dependent on BLK expression levels.

Authors:  Ying-Yu Wu; Ina Georg; Alejandro Díaz-Barreiro; Nieves Varela; Bernard Lauwerys; Ramesh Kumar; Harini Bagavant; Mireia Castillo-Martín; Fadi El Salem; Concepción Marañón; Marta E Alarcón-Riquelme
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

Review 5.  Contributions of B cells to lupus pathogenesis.

Authors:  Allison Sang; Ying-Yi Zheng; Laurence Morel
Journal:  Mol Immunol       Date:  2013-12-12       Impact factor: 4.407

6.  Surface receptor Toso controls B cell-mediated regulation of T cell immunity.

Authors:  Jinbo Yu; Vu Huy Hoang Duong; Katrin Westphal; Andreas Westphal; Abdulhadi Suwandi; Guntram A Grassl; Korbinian Brand; Andrew C Chan; Niko Föger; Kyeong-Hee Lee
Journal:  J Clin Invest       Date:  2018-04-03       Impact factor: 14.808

7.  C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

Authors:  Rama D Yammani; Marcela A Leyva; Ryan N Jennings; Karen M Haas
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

8.  Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus.

Authors:  Hari-Hara S K Potula; Zhiwei Xu; Leilani Zeumer; Allison Sang; Byron P Croker; Laurence Morel
Journal:  J Immunol       Date:  2012-08-15       Impact factor: 5.422

9.  Local renal autoantibody production in lupus nephritis.

Authors:  Marion Espeli; Susanne Bökers; Giovanna Giannico; Harriet A Dickinson; Victoria Bardsley; Agnes B Fogo; Kenneth G C Smith
Journal:  J Am Soc Nephrol       Date:  2010-11-18       Impact factor: 10.121

Review 10.  To B or not to B cells-mediate a healthy start to life.

Authors:  T G Nguyen; C M Ward; J M Morris
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.